Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/30797
Full metadata record
DC FieldValueLanguage
dc.creatorSantos-Garcia, Letícia-
dc.creatorAssis, Letícia C.-
dc.creatorDaniela R. Silva-
dc.creatorRamalho, Teodorico C.-
dc.creatorCunha, Elaine Fontes Ferreira da-
dc.date.accessioned2018-09-27T19:33:55Z-
dc.date.available2018-09-27T19:33:55Z-
dc.date.issued2016-
dc.identifier.citationSANTOS-GARCIA, L. et al. QSAR analysis of nicotinamidic compounds and design of potential Bruton’s tyrosine kinase (Btk) inhibitors. Journal of Biomolecular Structure and Dynamics, [S.l.], v. 34, n. 7, 2016.pt_BR
dc.identifier.urihttps://www.tandfonline.com/doi/abs/10.1080/07391102.2015.1070750?journalCode=tbsd20pt_BR
dc.identifier.urihttp://repositorio.ufla.br/jspui/handle/1/30797-
dc.description.abstractBruton’s tyrosine kinase (Btk) is an important enzyme in B-lymphocyte development and differentiation. Furthermore, Btk expression is considered essential for the proliferation and survival of these cells. Btk inhibition has become an attractive strategy for treating autoimmune diseases, B-cell leukemia, and lymphomas. With the objective of proposing new candidates for Btk inhibitors, we applied receptor-dependent four-dimensional quantitative structure–activity relationship (QSAR) methodology to a series of 96 nicotinamide analogs useful as Btk modulators. The QSAR models were developed using 71 compounds, the training set, and externally validated using 25 compounds, the test set. The conformations obtained by molecular dynamics simulation were overlapped in a virtual three-dimensional cubic box comprised of 2 and 5 Å cells, according to the six trial alignments. The models were generated by combining genetic function approximation and partial least squares regression technique. The analyses suggest that Model 1a yields the best results. The best equation shows , r2 = .743, RMSEC = .831, RMSECV = .879. Given the importance of the Tyr551, this residue could become a strategic target for the design of novel Btk inhibitors with improved potency. In addition, the good potency predicted for the proposed M2 compound indicates this compound as a potential Btk inhibitor candidate.pt_BR
dc.languageen_USpt_BR
dc.publisherTaylor and Francis Onlinept_BR
dc.rightsrestrictAccesspt_BR
dc.sourceJournal of Biomolecular Structure and Dynamicspt_BR
dc.subjectBruton’s tyrosine kinasept_BR
dc.subjectQuantitative structure-activity relationship (QSAR)pt_BR
dc.subjectNicotinamidept_BR
dc.titleQSAR analysis of nicotinamidic compounds and design of potential Bruton’s tyrosine kinase (Btk) inhibitorspt_BR
dc.typeArtigopt_BR
Appears in Collections:DQI - Artigos publicados em periódicos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.